China SXT Pharmaceuticals Inc
NASDAQ:SXTC

Watchlist Manager
China SXT Pharmaceuticals Inc Logo
China SXT Pharmaceuticals Inc
NASDAQ:SXTC
Watchlist
Price: 0.0822 USD -4.42%
Market Cap: $9.5m

Net Margin

-189.8%
Current
Improving
by 43.2%
vs 3-y average of -232.9%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-189.8%
=
Net Income
$-3.3m
/
Revenue
$1.7m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-189.8%
=
Net Income
$-3.3m
/
Revenue
$1.7m

Peer Comparison

Country Company Market Cap Net
Margin
CN
China SXT Pharmaceuticals Inc
NASDAQ:SXTC
9.5m USD
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
530.8B USD
Loading...
CH
Roche Holding AG
SIX:ROG
279.4B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
214.1B GBP
Loading...
CH
Novartis AG
SIX:NOVN
224.2B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
267.6B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
147.1B USD
Loading...
FR
Sanofi SA
PAR:SAN
96.7B EUR
Loading...

Market Distribution

Lower than 95% of companies in China
Percentile
5th
Based on 8 721 companies
5th percentile
-189.8%
Low
-416 945.9% — -1.5%
Typical Range
-1.5% — 8.9%
High
8.9% — 17 382.1%
Distribution Statistics
China
Min -416 945.9%
30th Percentile -1.5%
Median 3.5%
70th Percentile 8.9%
Max 17 382.1%

China SXT Pharmaceuticals Inc
Glance View

Market Cap
9.5m USD
Industry
Pharmaceuticals

China Sxt Pharmaceuticals, Inc. is a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 96 full-time employees. The company went IPO on 2019-01-04. The firm develops, manufactures and sells three types of TCMP products: advanced TCMP, fine TCMP and regular TCMP, and TCM Homologous Supplements (TCMHS) products. The firm sells its TCMP products under three brand names such as Suxuangtang, Hui Chun Tang and Tong Ren Tang. Most of its products are sold on a prescription basis across China.

SXTC Intrinsic Value
0.0936 USD
Undervaluation 12%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-189.8%
=
Net Income
$-3.3m
/
Revenue
$1.7m
What is China SXT Pharmaceuticals Inc's current Net Margin?

The current Net Margin for China SXT Pharmaceuticals Inc is -189.8%, which is above its 3-year median of -232.9%.

How has Net Margin changed over time?

Over the last 3 years, China SXT Pharmaceuticals Inc’s Net Margin has increased from -220.8% to -189.8%. During this period, it reached a low of -832% on Sep 30, 2023 and a high of 318.7% on Sep 30, 2024.

Back to Top